Revenue (Quarterly) Chart

View Revenue (Quarterly) for QTRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 32.91M
March 31, 2026 36.42M
December 31, 2025 43.86M
September 30, 2025 40.23M
June 30, 2025 24.48M
March 31, 2025 30.33M
December 31, 2024 35.16M
September 30, 2024 35.81M
June 30, 2024 34.38M
March 31, 2024 32.07M
December 31, 2023 31.55M
September 30, 2023 31.56M
June 30, 2023 30.80M
March 31, 2023 28.46M
December 31, 2022 25.82M
September 30, 2022 26.65M
June 30, 2022 23.50M
March 31, 2022 29.55M
December 31, 2021 30.29M
September 30, 2021 27.69M
June 30, 2021 25.37M
Date Value
March 31, 2021 27.21M
December 31, 2020 26.13M
September 30, 2020 31.39M
June 30, 2020 13.13M
March 31, 2020 15.73M
December 31, 2019 15.92M
September 30, 2019 14.94M
June 30, 2019 13.54M
March 31, 2019 12.34M
December 31, 2018 10.88M
September 30, 2018 10.59M
June 30, 2018 8.643M
March 31, 2018 7.521M
December 31, 2017 6.589M
September 30, 2017 5.734M
June 30, 2017 5.213M
March 31, 2017 5.338M
December 31, 2016 6.679M
September 30, 2016 3.402M
June 30, 2016 3.444M
March 31, 2016 4.06M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 1.878B
Bio-Rad Laboratories, Inc. 651.00M
Bruker Corp. 838.50M
Azenta, Inc. 161.18M
Danaher Corp. 6.265B